Abstract

Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to increasing clinical resistance to the gold standard drug metronidazole (MTZ). New potential antiparasitic compounds are usually tested for their killing efficacy against G. intestinalis under anaerobic conditions, in which MTZ is maximally effective. On the other hand, though commonly regarded as an ‘anaerobic pathogen,’ G. intestinalis is exposed to relatively high O2 levels in vivo, living attached to the mucosa of the proximal small intestine. It is thus important to test the effect of O2 when searching for novel potential antigiardial agents, as outlined in a previous study [Bahadur et al. (2014) Antimicrob. Agents Chemother. 58, 543]. Here, 45 novel chalcone derivatives with triazolyl-quinolone scaffold were synthesized, purified, and characterized by high resolution mass spectrometry, 1H and 13C nuclear magnetic resonance and infrared spectroscopy. Efficacy of the compounds against G. intestinalis trophozoites was tested under both anaerobic and microaerobic conditions, and selectivity was assessed in a counter-screen on human epithelial colorectal adenocarcinoma cells. MTZ was used as a positive control in the assays. All the tested compounds proved to be more effective against the parasite in the presence of O2, with the exception of MTZ that was less effective. Under anaerobiosis eighteen compounds were found to be as effective as MTZ or more (up to three to fourfold); the same compounds proved to be up to >100-fold more effective than MTZ under microaerobic conditions. Four of them represent potential candidates for the design of novel antigiardial drugs, being highly selective against Giardia trophozoites. This study further underlines the importance of taking O2 into account when testing novel potential antigiardial compounds.

Highlights

  • The amitochondriate protozoon Giardia intestinalis is a human parasite, causing extensive morbidity worldwide (Ankarklev et al, 2010)

  • The newly synthesized triazolyl-quinolone-based chalcone derivatives were characterized by High resolution mass spectroscopy (HRMS), 1H and 13C nuclear magnetic resonance (NMR) and IR spectroscopy, and relevant data are reported in Supplementary Material

  • Dose-response curves for each compound were obtained after 48 h-incubation and compared to the data collected under identical conditions with MTZ, the drug of choice for treatment of giardiasis

Read more

Summary

Introduction

The amitochondriate protozoon Giardia intestinalis is a human parasite, causing extensive morbidity worldwide (Ankarklev et al, 2010). The host is typically infected through ingestion of cyst-contaminated water or food. After exposure to the acidic environment of the stomach lumen, the cyst develops into the trophozoite, the vegetative form of the parasite, that in turn attaches to the mucosa of the proximal small intestine. This is the crucial step in establishing and maintaining the infection. The trophozoite starts proliferating, causing symptoms like diarrhea, malabsorption, dehydration, weight loss, failure to thrive, and chronic fatigue. The parasite is ready to be expelled into the environment and infect a new host, completing the life cycle

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call